Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting 2021-11-04 21:05
I-Mab to Present Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins's Lymphoma at ASH 2021 2021-11-04 21:00
Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference 2021-11-04 20:33
Taizhou, China: Building a Famous Chinese Medical City with Efforts 2021-11-04 20:16
Medigate Accelerates Expansion to Meet Growing Demand in Asia-Pacific Region 2021-11-04 20:15
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases 2021-11-04 19:30
Medtecs to showcase PPE and technologies from Taiwan at MEDICA 2021 2021-11-04 09:56
Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX 2021-11-03 22:00
TransThera Receives Fast Track Designation from FDA for its Core Product TT-00420 to Treat Cholangiocarcinoma 2021-11-03 22:00
Standigm Files PCT Patent Application of AI-driven Repurposed Drugs for Primary Mitochondrial Disease 2021-11-03 21:00
I-Mab Announces Upcoming Participation at November Conferences 2021-11-03 20:00
BioKangtai's adenovirus vector COVID-19 vaccine obtained EUA in Indonesia 2021-11-03 19:02
Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021 2021-11-03 15:00
Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join 2021-11-03 12:28
Kintor Pharma Doses First Patient in Clinical Trial of ALK-1 in Combination with KN046 In Advanced or Refractory Solid Tumors 2021-11-03 08:32
Daewoong's "Leaps and Bounds" Q3 Performance, Exceeds KRW 20B in Operating Income for Three Consecutive Quarters 2021-11-02 21:00
GenScript Expands Commercial Production in U.S. with State-of-the-Art Gene Synthesis Center 2021-11-02 19:30
PD-1/VEGF Bi-Specific Antibody (AK112) Obtained Approval to Initiate a Phase II Clinical Trial for Monotherapy or Combined Chemotherapy Neoadjuvant/Adjuvant Therapy of Resectable Non-Small Cell Lung Cancer 2021-11-02 11:53
New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA 2021-11-02 09:00
111 to Announce Third Quarter 2021 Unaudited Financial Results on November 19, 2021 - Conference Call to Follow 2021-11-02 04:57
1 192 193 194 195 196 802